Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The Pan-Bcl-2 Inhibitor GX15-O70 Induces Apoptosis in Human Myeloma Cells by Noxa Induction and Strongly Enhances Melphalan, Bortezomib or TRAIL-R1 Antibody Apoptotic Effect.

Patricia Gomez-Bougie, MD, PhD, Sophie Maïga, BSc, Catherine Pellat-Deceunynck, PhD, Sandrine Jouan, MSc, Regis Bataille, MD PhD, Martine Amiot, PhD

Blood (2006) 108 (11): 3476.

https://doi.org/10.1182/blood.V108.11.3476.3476

Published: 2006

Journal Articles

A Humanized Anti-IGF-1R Monoclonal Antibody (AVE1642) Synergizes with Bortezomib To Induce Apoptosis in CD45neg Myeloma Cells.

Geraldine Descamps, PhD, Soraya Wuilleme-Toumi, MD, Patricia Gomez-Bougie, MD, PhD, Corinne Venot, PhD, Friedhelm Bladt Bladt, PhD, Regis Bataille, MD, PhD, Martine Amiot, PhD

Blood (2006) 108 (11): 845.

https://doi.org/10.1182/blood.V108.11.845.845

Published: 2006

Journal Articles

The Complex Mcl-1/Bim Regulates the Sensitivity of Human Myeloma Cells to Melphalan.

Patricia Gomez-Bougie, MD, Lisa Oliver, PhD, Emmanuelle Menoret, Steven Le Gouill, MD, Régis Bataille, PHD, MD, Martine Amiot, PHD

Blood (2005) 106 (11): 357.

https://doi.org/10.1182/blood.V106.11.357.357

Published: 2005

Journal Articles

TRAILR Triggering by Human Antibodies Induces Apoptosis through an Early Cleavage of Mcl-1 and Caspase 3 in Myeloma Cells.

Catherine Pellat-Deceunynck, PhD, Patricia Gomez-Bougie, MD, Sylvanne Daniels, Alexandrine Geffroy-Luseau, Regis Bataille, MD, PhD, Martine Amiot, PhD

Blood (2005) 106 (11): 3397.

https://doi.org/10.1182/blood.V106.11.3397.3397

Published: 2005

Journal Articles

Mcl-1 Is Overexpressed in Multiple Myeloma and Correlates with Disease Severity.

Soraya Wuilleme-Toumi, MD, Nelly Robillard, PhD, Patricia Gomez-Bougie, MD, Philippe Moreau, MD, Steven Le Gouill, MD, Herve Avet-Loiseau, MD, PhD, Jean-Luc Harousseau, MD, Martine Amiot, PhD, Regis Bataille, MD, PhD

Blood (2004) 104 (11): 1419.

https://doi.org/10.1182/blood.V104.11.1419.1419

Published: 2004

Journal Articles

Mcl-1 Sequesters Pro-Apoptotic BH3-Only Bim To Inhibit Its Collaboration with Bax in Myeloma Cells.

Patricia Gomez-Bougie, MD, Monique Clement, PhD, Philipe Juin, PhD, Regis Bataille, MD, Martine Amiot, PhD

Blood (2004) 104 (11): 789.

https://doi.org/10.1182/blood.V104.11.789.789

Published: 2004

NARROW

The Pan-Bcl-2 Inhibitor GX15-O70 Induces Apoptosis in Human Myeloma Cells by Noxa Induction and Strongly Enhances Melphalan, Bortezomib or TRAIL-R1 Antibody Apoptotic Effect.

A Humanized Anti-IGF-1R Monoclonal Antibody (AVE1642) Synergizes with Bortezomib To Induce Apoptosis in CD45neg Myeloma Cells.

The Complex Mcl-1/Bim Regulates the Sensitivity of Human Myeloma Cells to Melphalan.

TRAILR Triggering by Human Antibodies Induces Apoptosis through an Early Cleavage of Mcl-1 and Caspase 3 in Myeloma Cells.

Mcl-1 Is Overexpressed in Multiple Myeloma and Correlates with Disease Severity.

Mcl-1 Sequesters Pro-Apoptotic BH3-Only Bim To Inhibit Its Collaboration with Bax in Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

The Pan-Bcl-2 Inhibitor GX15-O70 Induces Apoptosis in Human Myeloma Cells by Noxa Induction and Strongly Enhances Melphalan, Bortezomib or TRAIL-R1 Antibody Apoptotic Effect.

A Humanized Anti-IGF-1R Monoclonal Antibody (AVE1642) Synergizes with Bortezomib To Induce Apoptosis in CD45neg Myeloma Cells.

The Complex Mcl-1/Bim Regulates the Sensitivity of Human Myeloma Cells to Melphalan.

TRAILR Triggering by Human Antibodies Induces Apoptosis through an Early Cleavage of Mcl-1 and Caspase 3 in Myeloma Cells.

Mcl-1 Is Overexpressed in Multiple Myeloma and Correlates with Disease Severity.

Mcl-1 Sequesters Pro-Apoptotic BH3-Only Bim To Inhibit Its Collaboration with Bax in Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only